Key result
Epicardial mapping and ablation via subxyphoid access improves the management and success rates of complex ventricular tachycardia in patients with structural heart diseases.
Why the study?
Does epicardial mapping and ablation improve success rates in patients with ventricular tachycardia and structural heart disease?
Does epicardial mapping and ablation improve success rates in patients with ventricular tachycardia and structural heart disease?
Epicardial mapping and ablation via subxyphoid access is a crucial technique for improving success rates in complex ventricular tachycardia, especially when endocardial ablation fails due to deep intramural or subepicardial foci.
Supports subxyphoid epicardial access for refractory VT; leaves open need for prospective trials on safety and durability.
Ventricular tachyarrhythmias are among the main problems in cardiology and electrophysiology. Drugs treatment is often ineffective in patients with ventricular tachycardia (VT), while interventional approach is more successful. Nevertheless, despite the progress in visualization and catheter ablation technologies, there is still significant ventricular tachycardia recurrence rate over time. There is a number of reports showing that the main cause of endocardial ablation failure is deep intramural and subepicardial location of arrhythmogenic foci. An elegant percutaneous technique using a subxyphoid access has been proposed in order to reach the pericardial space. Combination of endoand epicardial mapping and ablation has revolutionized ventricular tachycardia management in patients with structural heart diseases, allowing much better success in specific patient population. This review summarizes current achievements in epicardial mapping and ablation in complex ventricular tachycardia management.
No takes yet. Share an insight, caveat, or question.
Симонова et al. (2017) conducted a review in Ventricular tachycardia. Epicardial mapping and ablation was evaluated. Epicardial mapping and ablation via subxyphoid access improves the management and success rates of complex ventricular tachycardia in patients with structural heart diseases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: